Stock Events

Stock Events

Filana Therapeutics 

M$56.00
354
+M$0.00+0% Wednesday 16:55

Statistics

Day High
56
Day Low
56
52W High
86
52W Low
37
Volume
0
Avg. Volume
7
Mkt Cap
2.71B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 12
M$67.15
Dec 10
M$24.81
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11NovExpected
Q1 2026
Q2 2026
Next
-0.25
-0.22
-0.2
-0.18
Expected EPS
-0.245
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-2.86BNet Income

Analyst Ratings

68.00Average Price Target
The highest estimate is 68.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.28B
Biogen is a leading competitor in the Alzheimer's treatment market, directly competing with Cassava's simufilam.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has developed donanemab, an Alzheimer's disease treatment, competing in the same space as Cassava Sciences.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a history of developing treatments for neurological disorders, including Alzheimer's, making it a competitor.
AC Immune SA
ACIU
Mkt Cap263.48M
AC Immune SA focuses on developing treatments for neurodegenerative diseases, including Alzheimer's, directly competing with Cassava.
Annovis Bio
ANVS
Mkt Cap73.28M
Annovis Bio operates in the Alzheimer's and Parkinson's disease space, making it a competitor to Cassava Sciences.
Anavex Life Sciences
AVXL
Mkt Cap277.16M
Anavex Life Sciences Corp. is working on treatments for Alzheimer's disease, competing in the same market as Cassava.

About

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Show more...
CEO
Mr. Remi Barbier
Employees
24
Country
United States
ISIN
US14817C1071

Listings

MX
MX
FLNA.MX
F
DE
PX91.F
STU
DE
PX91.STU
MU
DE
PX91.MU

0 Comments

Share your thoughts

FAQ

What is Filana Therapeutics stock price today?▼
The current price of SAVA.MX is M$56.00 MXN — it has increased by +0% in the past 24 hours. Watch Filana Therapeutics stock price performance more closely on the chart.
What is Filana Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Filana Therapeutics stocks are traded under the ticker SAVA.MX.
Is Filana Therapeutics stock price growing?▼
SAVA.MX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Filana Therapeutics has showed a +22.81% increase.
What is Filana Therapeutics market cap?▼
Today Filana Therapeutics has the market capitalization of 2.71B
What is Filana Therapeutics revenue for the last year?▼
Filana Therapeutics revenue for the last year amounts to 0 MXN.
What is Filana Therapeutics net income for the last year?▼
SAVA.MX net income for the last year is -2.86B MXN.
Does Filana Therapeutics pay dividends?▼
Yes, SAVA.MX dividends are paid en. The last dividend per share was 67.15 MXN. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Filana Therapeutics have?▼
As of September 04, 2026, the company has 24 employees.
In which sector is Filana Therapeutics located?▼
Filana Therapeutics operates in the Health & Wellness sector.
When did Filana Therapeutics complete a stock split?▼
The last stock split for Filana Therapeutics was on December 21, 2023 with a ratio of 14:10.
Where is Filana Therapeutics headquartered?▼
Filana Therapeutics is headquartered in Austin, United States.